UMMS Affiliation

Commonwealth Medicine, Clinical Pharmacy Services

Publication Date

2016-11-16

Document Type

Presentation

Disciplines

Health Economics | Health Law and Policy | Health Policy | Health Services Administration | Health Services Research | Pharmacoeconomics and Pharmaceutical Economics | Pharmacy Administration, Policy and Regulation

Abstract

Specialty drug spend increased by 15 percent to $121 billion in 2015 and is projected to rise even more. Budget-conscious payers need to implement novel management strategies that anticipate the cost of specialty medications before they’re available. A summary of efficacy data for high-impact specialty pipeline drugs expected to reach the market, including their place in therapy and budgetary impact. Also featured are strategies to mitigate costs of these cutting-edge medications and compare them to current therapy options.

Keywords

specialty medications, specialty drugs, drug spend, pharmacy, drug utilization review

DOI of Published Version

10.13028/bvn5-f308

Journal/Book/Conference Title

Eastern Medicaid Pharmacy Administrators Association 40th Annual Meeting

Comments

Presented at the Eastern Medicaid Pharmacy Administrators Association 40th Annual Meeting.

Share

COinS